• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清急性期反应物在卵巢肿瘤患者中的临床应用价值

Clinical usefulness of serum acute-phase reactants in patients with ovarian tumors.

作者信息

Warwas M, Dobryszycka W, Gerber J, Pietkiewicz A

出版信息

Neoplasma. 1981;28(4):485-90.

PMID:7290269
Abstract

Concentrations of the following acute-phase reactants (APR) were determined in the sera of patients with benign and malignant ovarian tumors: haptoglobin, ceruloplasmin, sialic acid, seromucoid (in sulphosalicylic acid supernatant), and trypsin inhibitory capacity. In patients with ovarian carcinomas significant increase (p less than 0.001) in all measured APR parameters as compared to healthy women and women with benign tumors was found. Moreover, the levels of haptoglobin, ceruloplasmin and trypsin inhibitory capacity were statistically lower (p less than 0.001) in nonmalignant than in malignant ovarian disease. No distinct statistical difference was confirmed between healthy controls and the benign tumor group as well as between ovarian carcinomas of Stages I--III and Stage IV.

摘要

在患有良性和恶性卵巢肿瘤的患者血清中测定了以下急性期反应物(APR)的浓度:触珠蛋白、铜蓝蛋白、唾液酸、血清类粘蛋白(磺基水杨酸上清液中)和胰蛋白酶抑制能力。与健康女性和患有良性肿瘤的女性相比,发现卵巢癌患者所有测量的APR参数均显著升高(p<0.001)。此外,非恶性卵巢疾病中触珠蛋白、铜蓝蛋白和胰蛋白酶抑制能力的水平在统计学上低于恶性卵巢疾病(p<0.001)。健康对照组与良性肿瘤组之间以及I-III期和IV期卵巢癌之间未证实有明显的统计学差异。

相似文献

1
Clinical usefulness of serum acute-phase reactants in patients with ovarian tumors.血清急性期反应物在卵巢肿瘤患者中的临床应用价值
Neoplasma. 1981;28(4):485-90.
2
Acute phase reactants and circulating immune complexes in patients with ovarian carcinoma.卵巢癌患者的急性期反应物与循环免疫复合物
Arch Immunol Ther Exp (Warsz). 1991;39(1-2):41-50.
3
Haptoglobin and proteinase inhibitors in the blood serum of women with inflammatory, benign and neoplastic lesions of the ovary.
Neoplasma. 1986;33(1):79-84.
4
Changes of serum proteins in patients with malignant gynaecological tumours.
Acta Chir Hung. 1988;29(4):305-14.
5
Serum haptoglobin, CA 125 and interleukin 6 levels in malignant and non-malignant tumors of the ovary.卵巢良恶性肿瘤患者血清触珠蛋白、CA 125及白细胞介素6水平
Arch Immunol Ther Exp (Warsz). 1999;47(4):229-36.
6
Preoperative serum thrombopoietin levels are higher in patients with ovarian cancer than with benign cysts.卵巢癌患者术前血清血小板生成素水平高于良性囊肿患者。
Eur J Obstet Gynecol Reprod Biol. 2008 Sep;140(1):67-70. doi: 10.1016/j.ejogrb.2005.10.037. Epub 2005 Dec 15.
7
[Factors of the "acute phase" in proliferative diseases of the hemopoietic system].
Wiad Lek. 1992 Sep;45(17-18):659-64.
8
Changes in insulin-like growth factor I, 17-b-estradiol, and progesterone in postmenopausal women with benign and malignant ovarian tumours.患有良性和恶性卵巢肿瘤的绝经后女性体内胰岛素样生长因子I、17-β-雌二醇和孕酮的变化。
Med Sci Monit. 2001 Sep-Oct;7(5):919-23.
9
Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women.绝经后妇女良性和恶性上皮性卵巢肿瘤中的血清胰岛素样生长因子(IGF)-I、IGF结合蛋白(IGFBP)-3、瘦素浓度及胰岛素抵抗
Gynecol Endocrinol. 2008 Mar;24(3):117-21. doi: 10.1080/09513590801895559.
10
Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.恶性和非恶性疾病患者血清及积液中的血管内皮生长因子
Cancer. 1999 Jan 1;85(1):178-87.

引用本文的文献

1
Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer.循环中的触珠蛋白是上皮性卵巢癌患者血清中的一个独立预后因素。
Neoplasia. 2007 Jan;9(1):1-7. doi: 10.1593/neo.06619.